Results 141 to 150 of about 4,041,072 (252)

The impact of risk perception on perceived benefits of generative artificial intelligence users-an empirical study based on university students. [PDF]

Front Psychol
Du W, Ning S, Shi Y, Chen Y.
europepmc   +1 more source

Spatial and Volumetric Characteristics of Glioblastoma: Associations With Clinical Presentation and Survival

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective We aim to comprehensively analyze how regional tumor and edema characteristics are associated with clinical presentations and survival outcomes in a large cohort of glioblastoma patients. Methods Patients with IDH‐wildtype glioblastoma who received brain MRI from 2010 to 2023 were included.
Daniel J. Zhou, Marc Jaskir, Julian Gal, Yombe Fonkeu, Christos Davatzikos, MacLean P. Nasrallah, Jose Garcia, Rubo Xing, Stephen J. Bagley, Arati Desai, Richard E. Phillips, Steven Tobochnik, Colin A. Ellis, James J. Gugger, Nishant Sinha, Joel M. Stein, Kathryn A. Davis   +16 more
wiley   +1 more source

Sauna bathing: motivations, perceived benefits, and gender differences- a descriptive health promotion study. [PDF]

Int J Circumpolar Health
Engström Å, Wiell K, Hägglund H, Lennkvist M.   +3 more
europepmc   +1 more source

Long‐Term Efficacy of Immunotherapy in Autoimmune Autonomic Ganglionopathy—A 10‐Year Follow Up Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Autoimmune autonomic ganglionopathy (AAG) is a rare but potentially treatable cause of severe autonomic failure. Evidence guiding long‐term immunotherapy, treatment sequencing, and residual autonomic impairment is limited. We evaluated long‐term treatment response, residual autonomic dysfunction, and relapse patterns in patients with
Giacomo Chiaro, Shiwen Koay, Gordon T. Ingle, Patricia McNamara, Laura Watson, Fion Bremner, Valeria Iodice   +6 more
wiley   +1 more source

Accounting honours programmes: perceived benefits

The present study extended the findings of a previous study that honours programmes provide substantial benefits to faculty academics, students and professional accounting recruiters.
Kosmas X. Smyrnios, Claudio A. Romano
core   +1 more source

Adverse effects and perceived benefits of medications in children with chronic noncancer pain. [PDF]

Front Pain Res (Lausanne)
Niburski K, Mohamed N, Dundaru-Bandi D, Gonzalez Cardenas VH, Vigouroux M, Pitt R, Ingelmo P.   +6 more
europepmc   +1 more source

Evaluation of Digital Technologies for Home‐Based Assessment in People With Amyotrophic Lateral Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Digital technologies hold promise for transforming healthcare by enhancing personalized treatments and offer valuable opportunities to improve patient care. Here, we evaluated several novel, self‐administered, home‐based, digital endpoints for their association with corresponding conventional standard clinical measures (primary) in ...
Arne Mueller, Vanessa Vallejo, Mónica Povedano Panadés, Orla Hardiman, Véronique Danel‐Brunaud, Senda Ajroud‐Driss, Philippe Couratier, Jeremy Shefner, Anna Gokey, Mike DiCesare, Erin Lennox, Jens Praestgaard, Lucie Brujin, Peggy Allred, Ram Miller   +14 more
wiley   +1 more source

VA benefits for survivors.

, 2010
Shipping list no.: 2010-0279-P."Rescission: VA pamphlet 21-03-1, dated May 2006"--P. [6]."March 2010.""...to care for him who shall have borne the battle, and for his widow and his orphan ..."--Abraham Lincoln.Cover title.Mode of access ...
United States. Veterans Benefits Administration.
core  

Treatment choices: insights into disease-specific use and self-perceived benefits of traditional, complementary and integrative medicine in Germany. [PDF]

BMC Complement Med Ther
von Schoen-Angerer T, Wischnewsky M, Jeitler M, Brinkhaus B, Ortiz M, Hoffmann R, Kessler CS.   +6 more
europepmc   +1 more source

Unraveling 4‐Phenylbutyrate's Therapeutic Role in SLC6A1 Disorders: Pharmacochaperoning Over HDAC Inhibition

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Variants in SLC6A1, encoding the GABA transporter 1 (GAT‐1), cause epilepsy, autism spectrum disorder, and developmental delay via loss of GABA uptake, impaired trafficking, and ER retention. We previously found that 4‐Phenylbutyrate (PBA), an FDA‐approved drug, restores GABA uptake and reduces seizures in SLC6A1‐related disorders ...
Melissa B. DeLeeuw, Karishma Randhave, Ekta Anand, Ziang (Debbie) Song, Wangzhen Shen, Jing‐Qiong Kang   +5 more
wiley   +1 more source